The renal response to FGF23 shifts from phosphaturia toward inflammation in kidney disease. [PDF]
Moor MB +10 more
europepmc +1 more source
Burosumab treatment in an adult with FGF23-mediated hypophosphatemia due to cutaneous skeletal hypophosphatemia syndrome. [PDF]
Tosi LL +5 more
europepmc +1 more source
Genetics of Response to Canagliflozin (GRC) Study: Rationale, Design, and Pharmacodynamic Responses. [PDF]
Montasser ME +10 more
europepmc +1 more source
XLH Matters 2024 GCC Edition: Insights and Recommendations to Improve Outcomes for People Living With XLH in the Gulf Region. [PDF]
Seefried L +10 more
europepmc +1 more source
Tumor induced-osteomalacia caused by a phosphaturic mesenchymal tumor in the sartorius muscle: a case report. [PDF]
Rymon Lipinska W +3 more
europepmc +1 more source
Long-term survival and phenotypic expansion in siblings with generalized arterial calcification of infancy. [PDF]
Resnick O, Ashraf A.
europepmc +1 more source
Pre-Parathyroidectomy PTH as an Integrated Biomarker of Glandular Remodeling and Skeletal Turnover in Secondary Hyperparathyroidism. [PDF]
Liao MT +6 more
europepmc +1 more source
Burosumab an emerging therapy in TIO: a local clinical survey and a systematic review with individual patient data analysis. [PDF]
Vergatti A +9 more
europepmc +1 more source

